ArticleBMJ open2012
A question-answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study.
Article in BMJ open, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Future Clinical Pharmacological Decision Support.Basic & clinical pharmacology & toxicology · 2026Article
- The perceived development needs for medicines information services in university hospital pharmacies: A mixed methods study.Exploratory research in clinical and social pharmacy · 2022Article
- Review of Clinical Questions Submitted to Norwegian Drug Information Centres Concerning Administration and Dosage to Older Patients of Relevance to Patient-Centric Care.Pharmaceutics · 2021Article
- Quetiapine, Misuse and Dependency: A Case-Series of Questions to a Norwegian Network of Drug Information Centers.Drug, healthcare and patient safety · 2021Article
- Review of Questions Concerning Clinical Drug Interactions in ADHD Treatment From Physicians in Norway.Frontiers in pharmacology · 2020Article
- Drug information centre queries and responses about drug interactions over 10 years-A descriptive analysis.Basic & clinical pharmacology & toxicology · 2020Article
- Disproportionality analysis for identification of drug safety signals in a database shared by the Norwegian network of drug information centres (RELIS).European journal of clinical pharmacology · 2019Article
- Norwegian drug information centres strongly promote person-centred and personalised medicine: a brief report on the achievements and strategy.The EPMA journal · 2019Review
- Use of References in Responses from Scandinavian Drug Information Centres.Medicines (Basel, Switzerland) · 2018Article
- Analysis of questions about use of drugs in breastfeeding to Norwegian drug information centres.International breastfeeding journal · 2018Article
- Quality assessment of structure and language elements of written responses given by seven Scandinavian drug information centres.European journal of clinical pharmacology · 2017Article
- Benefits of a national network of drug information centres: RELIS.European journal of clinical pharmacology · 2017Article
- Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study.European journal of clinical pharmacology · 2014Article
- Questions about complementary and alternative medicine to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive pilot study.BMC complementary and alternative medicine · 2014Article
- Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems.Drug, healthcare and patient safety · 2014Article
- Annual report on adverse events related with vaccines use in Calabria (Italy): 2012.Journal of pharmacology & pharmacotherapeutics · 2013Article
- Clinical pharmacology in everyday clinical care.European journal of clinical pharmacology · 2013Article
- Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess a question-answer pair (QAP) database integrated with websites developed for drug information centres to answer complex questions effectively.
designDescriptive study with comparison of two subsequent 6-year periods (1995-2000 and 2001-2006).
settingThe Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS).
participantsA randomised sample of QAPs from the RELIS database. PRIMARY OUTCOME MEASURE: Answer time in days compared with Mann-Whitney U test. SECONDARY OUTCOME MEASURE: Number of drugs involved (one, two, three or more), complexity (judgemental and/or patient-related or not) and literature search (none, simple or advanced) compared with χ(2) tests.
results842 QAPs (312 from 1995 to 2000 and 530 from 2001 to 2006) were compared. The fraction of judgemental and patient-related questions increased (66%-75% and 54%-72%, respectively, p<0.01). Number of drugs and literature search (>50% advanced) was similar in the two periods, but the fraction of answers referring to the RELIS database increased (13%-31%, p<0.01). Median answer time was reduced from 2 days to 1 (p<0.01), although the fraction of complex questions increased from the first to the second period. Furthermore, the mean number of questions per employee per year increased from 66 to 89 from the first to the second period.
conclusionsThe authors conclude that RELIS has a potential to efficiently answer complex questions. The model is of relevance for organisation of drug information centres.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.